...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: New Frontiers for both RVX/Zenith

Chicago, given your personal interest if you want to look further wrt Apabetalone and heart failure you might start with the RVX news release of Jan 2, 2014 "Publications Confirm RVX-208 is a Unique Selective BET Bromodomain Antagonist".  In the release it references a publication in Cell Journal regarding the potential of BET Inhibitors, including RVX-208, and their potential as therapeutics for heart failure.

Share
New Message
Please login to post a reply